INVESTABOT
Equity Research
XNYS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Bristol-Myers Squibb (BMY) had 1 Form 144 pre-sale notice filed on 2026-09-09. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Bristol-Myers Squibb (BMY) had 1 Form 144 pre-sale notice filed on 2026-08-25. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
TL;DR: Bristol-Myers Squibb generated $11.49B in Q1 2026 revenue, up 2.6% from $11.20B a year ago, while net income came in at $2.68B and GAAP EPS landed at $1.31.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 2 unique sellers · 6 accumulating - 7 trimming - 1 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 9, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | SELL | -6,249 | $65 | ~$0.4M |
| September 1, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | OPTION_EXERCISE | 1,236 | $67 | ~$83K |
| September 1, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | TAX_WITHHOLD | -633 | $67 | ~$42K |
| September 1, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | OPTION_EXERCISE | -1,236 | — | — |
| August 25, 2026 | Holzer Phil M | SVP and Controller | SELL | -500 | $68 | ~$34K |
| August 1, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | OPTION_EXERCISE | 51,172 | — | — |
| August 1, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | TAX_WITHHOLD | -26,175 | $65 | ~$1.7M |
| August 1, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | OPTION_EXERCISE | -51,172 | — | — |
| August 1, 2026 | Gallman Cari | EVP, General Counsel | OPTION_EXERCISE | 1,061 | — | — |
| August 1, 2026 | Gallman Cari | EVP, General Counsel | TAX_WITHHOLD | -543 | $65 | ~$35K |
| August 1, 2026 | Gallman Cari | EVP, General Counsel | OPTION_EXERCISE | -1,061 | — | — |
| June 30, 2026 | Yale Phyllis R | — | GRANT | 607.43 | $58 | ~$35K |
| June 30, 2026 | Samuels Theodore R. II | — | GRANT | 889.45 | $58 | ~$51K |
| June 30, 2026 | Rice Derica W | — | GRANT | 672.51 | $58 | ~$39K |
| June 30, 2026 | McMullen Michael R. | — | GRANT | 607.43 | $58 | ~$35K |
| June 30, 2026 | Arduini Peter J | — | GRANT | 607.43 | $58 | ~$35K |
| June 15, 2026 | Haller Julia A | — | OPTION_EXERCISE | 20,460 | $54 | ~$1.1M |
| June 15, 2026 | Haller Julia A | — | OPTION_EXERCISE | -20,460 | — | — |
| June 3, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | OPTION_EXERCISE | 8,040 | — | — |
| June 3, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | TAX_WITHHOLD | -3,876 | $55 | ~$0.2M |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 198,727,768 | ~$10.7B | — | January 29, 2026 |
| BlackRock | 171,682,888 | ~$10.4B | -2.9% | May 13, 2026 |
| BlackRock | 180,384,994 | ~$10.4B | 5.1% | August 7, 2026 |
| BlackRock | 176,825,406 | ~$9.5B | — | February 12, 2026 |
| BlackRock | 158,658,853 | ~$6.6B | — | August 13, 2024 |
| State Street | 98,564,914 | ~$6.0B | 0.6% | May 15, 2026 |
| State Street | 102,408,940 | ~$5.9B | 3.9% | August 7, 2026 |
| JP Morgan Chase | 96,171,217 | ~$5.7B | 19.1% | May 13, 2026 |
| State Street | 97,980,438 | ~$5.3B | — | February 13, 2026 |
| JP Morgan Chase | 74,817,565 | ~$4.4B | -22.2% | August 12, 2026 |
| JP Morgan Chase | 80,716,176 | ~$4.4B | — | February 11, 2026 |
| AQR Capital | 29,631,105 | ~$1.8B | 14.9% | May 15, 2026 |
| Morgan Stanley | 29,198,673 | ~$1.8B | 3.0% | May 15, 2026 |
| Morgan Stanley | 29,009,144 | ~$1.7B | -0.7% | August 13, 2026 |
| AQR Capital | 27,357,486 | ~$1.6B | -7.7% | August 14, 2026 |
| Morgan Stanley | 28,348,756 | ~$1.5B | — | May 27, 2026 |
| AQR Capital | 25,796,905 | ~$1.4B | — | February 17, 2026 |
| Goldman Sachs | 18,893,877 | ~$1.0B | — | March 25, 2026 |
| Goldman Sachs | 17,427,999 | ~$1.0B | 19.7% | August 14, 2026 |
| Fidelity (FMR) | 16,293,303 | ~$938.8M | 52.7% | August 13, 2026 |